HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
KRT20
keratin 20
Chromosome 17 · 17q21.2
NCBI Gene: 54474Ensembl: ENSG00000171431.5HGNC: HGNC:20412UniProt: P35900
125PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
cytoplasmprotein bindingcytosolintermediate filament organizationneoplasmchronic lymphocytic leukemiaacute lymphoblastic leukemiamyeloid sarcoma
✦AI Summary

KRT20 (keratin 20) is a structural protein that maintains keratin filament organization in intestinal epithelia 1. When phosphorylated, it plays a role in mucin secretion in the small intestine. Beyond normal epithelial function, KRT20 serves as a marker of differentiated cells in colorectal cancer, with KRT20+ cells representing post-mitotic progeny that can revert to cancer stem cells after therapeutic ablation 2. KRT20 expression patterns have significant clinical implications across multiple cancer types. In head and neck squamous cell carcinoma, KRT20 overexpression increases migration and invasion capacity and correlates with lymphatic metastasis and poor prognosis 3. In bladder cancer, high KRT20 expression combined with low KRT5 expression identifies aggressive luminal subtypes with worse recurrence-free and progression-free survival 45. High KRT20-expressing tumors are enriched for aggressive urothelial variants including micropapillary and plasmacytoid subtypes 5. In colorectal carcinoma, KRT20 loss correlates primarily with microsatellite instability-high status 1. KRT20 mRNA detection in peritoneal lavage fluid shows promise as a predictor of gastric cancer recurrence 6. In interstitial cystitis, reduced KRT20 expression distinguishes Hunner-type from non-Hunner-type disease 7.

Sources cited
1
KRT20 marks differentiated cancer cells in colorectal cancer that contribute to tumor regrowth after cancer stem cell ablation
PMID: 28355176
2
KRT20 is a key gene associated with lymphatic metastasis in HNSCC; overexpression increases migration and invasion; high expression predicts adverse prognosis
PMID: 35815926
3
KRT20 serves as intestinal epithelium-specific marker; decreased expression correlates with MSI-H status in colorectal carcinomas
PMID: 35029777
4
KRT20 mRNA in peritoneal lavage fluid correlates with tumor invasion depth and lymph node metastasis in gastric cancer
PMID: 35896219
5
High KRT20 with low KRT5 identifies luminal subtype and predicts worse recurrence-free and progression-free survival in stage pT1 bladder cancer
PMID: 28074276
6
High KRT20 expression associates with poor disease-specific survival and aggressive urothelial carcinoma variants in muscle-invasive bladder cancer
PMID: 30380731
7
KRT20 expression level combined with survivin/BIRC5 levels predicts outcomes in adjuvant-treated muscle-invasive bladder cancer
PMID: 33050010
8
KRT20 is a biomarker that distinguishes Hunner-type from non-Hunner-type interstitial cystitis, with lower expression in Hunner-type
PMID: 35102612
Disease Associationsⓘ20
neoplasmOpen Targets
0.12Weak
chronic lymphocytic leukemiaOpen Targets
0.11Weak
acute lymphoblastic leukemiaOpen Targets
0.11Weak
myeloid sarcomaOpen Targets
0.11Weak
diffuse large B-cell lymphomaOpen Targets
0.11Weak
non-Hodgkins lymphomaOpen Targets
0.11Weak
infectionOpen Targets
0.11Weak
colorectal carcinomaOpen Targets
0.11Weak
melanomaOpen Targets
0.10Weak
rheumatoid arthritisOpen Targets
0.10Weak
COVID-19Open Targets
0.10Weak
cancerOpen Targets
0.10Weak
head and neck squamous cell carcinomaOpen Targets
0.09Suggestive
Barrett's esophagusOpen Targets
0.09Suggestive
lymphomaOpen Targets
0.09Suggestive
B-cell non-Hodgkins lymphomaOpen Targets
0.09Suggestive
triple-negative breast cancerOpen Targets
0.09Suggestive
diabetes mellitusOpen Targets
0.09Suggestive
experimental autoimmune encephalomyelitisOpen Targets
0.09Suggestive
systemic lupus erythematosusOpen Targets
0.08Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
CDX2Protein interaction92%SYPProtein interaction87%CEACAM5Protein interaction87%NKX2-1Protein interaction84%PIPProtein interaction84%NAPSAProtein interaction82%
Tissue Expression6 tissues
Liver
100%
Ovary
80%
Lung
20%
Heart
0%
Brain
0%
Bone Marrow
0%
Gene Interaction Network
Click a node to explore
KRT20CDX2SYPCEACAM5NKX2-1PIPNAPSA
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt P35900
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
1.26LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.95 [0.72–1.26]
RankingsWhere KRT20 stands among ~20K protein-coding genes
  • #3,770of 20,598
    Most Researched125 · top quartile
  • #13,270of 17,882
    Most Constrained (LOEUF)1.26
Genes detectedKRT20
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
Visualization and targeting of LGR5
PMID: 28355176
Nature · 2017
1.00
2
Identifying KRT20 as a Potential Key Gene in Lymphatic Metastasis of Head and Neck Squamous Cell Carcinoma.
PMID: 35815926
Technol Cancer Res Treat · 2022
0.90
3
Comprehensive clinicopathologic, molecular, and immunologic characterization of colorectal carcinomas with loss of three intestinal markers, CDX2, SATB2, and KRT20.
PMID: 35029777
Virchows Arch · 2022
0.80
4
Editorial Comment to Supervised machine learning algorithm identified KRT20, BATF and TP63 as biologically relevant biomarkers for bladder biopsy specimens from interstitial cystitis/bladder pain syndrome patients.
PMID: 35124850
Int J Urol · 2022
0.70
5
Significance of Intraperitoneal-free
PMID: 35896219
Anticancer Res · 2022
0.60